Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.


Stock Performance

BMY vs. S&P 500 | 2 Year Performance
View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $53.87
Prev Close: $55.09
Open: $55.26
Bid: $53.98
Ask: $54.02
Day's Range: $53.76 - $55.27
52wk Range: $53.76 - $77.12
Volume: 17,223,034
Avg Vol 12,083,010
Market Cap: $89.87B
P/E (ttm): 19.75
EPS (ttm): $2.79
Div & Yield: $1.52 (2.8%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1740 Outperform
114 Underperform
CAPS All Stars
 
445 Outperform
16 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

83% Approve

Based on 146 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers